Swiss National Bank Immuno Gen, Inc. Transaction History

Swiss National Bank

$150 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 08, 2023	BUY	$14.09 - $19.87 $66,223 - $93,389	4,700 Added 0.99%	480,800 $7.63 Million
Q2 2023 Aug 09, 2023	BUY	$3.75 - $20.05 $177,375 - $948,365	47,300 Added 11.03%	476,100 $8.98 Million
Q1 2023 May 10, 2023	SELL	$3.67 - $4.92 $186,436 - $249,936	-50,800 Reduced 10.59%	428,800 $1.65 Million
Q4 2022 Feb 08, 2023	BUY	$4.55 - $6.31 $40,495 - $56,159	8,900 Added 1.89%	479,600 $2.38 Million
Q3 2022 Nov 09, 2022	BUY	$4.48 - $6.47 $14,336 - $20,704	3,200 Added 0.68%	470,700 $2.25 Million
Q2 2022 Aug 09, 2022	SELL	$3.15 - $5.76 $36,540 - $66,816	-11,600 Reduced 2.42%	467,500 $2.1 Million
Q1 2022 May 09, 2022	BUY	$4.26 - $7.48 $143,988 - $252,824	33,800 Added 7.59%	479,100 $2.28 Million
Q4 2021 Feb 08, 2022	BUY	$4.75 - $7.5 $16,625 - $26,250	3,500 Added 0.79%	445,300 $3.3 Million
Q3 2021 Nov 08, 2021	BUY	$5.02 - $6.59 $67,268 - $88,306	13,400 Added 3.13%	441,800 $2.51 Million
Q1 2021 May 07, 2021	BUY	$6.5 - $10.53 $215,150 - $348,543	33,100 Added 8.37%	428,400 $3.47 Million
Q3 2020 Nov 09, 2020	BUY	$3.45 - $4.89 $30,015 - $42,543	8,700 Added 2.25%	395,300 $1.42 Million
Q2 2020 Aug 05, 2020	BUY	$3.32 - $5.34 $182,268 - $293,166	54,900 Added 16.55%	386,600 $1.78 Million
Q1 2020 May 08, 2020	BUY	$2.12 - $6.8 $94,976 - $304,640	44,800 Added 15.62%	331,700 $1.13 Million
Q4 2019 Feb 06, 2020	BUY	$2.25 - $5.8 $14,175 - $36,540	6,300 Added 2.25%	286,900 $1.47 Million
Q3 2019 Nov 12, 2019	BUY	$2.22 - $3.39 $19,758 - $30,171	8,900 Added 3.28%	280,600 $679,000
Q1 2019 May 10, 2019	BUY	$2.41 - $5.91 $19,762 - $48,462	8,200 Added 3.11%	271,700 $736,000
Q4 2018 Feb 13, 2019	BUY	$3.94 - $9.7 $37,430 - $92,150	9,500 Added 3.74%	263,500 $1.27 Million
Q2 2018 Aug 09, 2018	BUY	$9.52 - $12.15 $337,008 - $430,110	35,400 Added 16.19%	254,000 $2.47 Million
Q1 2018 May 04, 2018	BUY	$6.7 - $12.95 $384,580 - $743,330	57,400 Added 35.61%	218,600 $2.3 Million
Q4 2017 Feb 07, 2018	BUY	$5.07 - $7.92 $116,610 - $182,160	23,000 Added 16.64%	161,200 $1.03 Million
Q3 2017 Nov 03, 2017	BUY	$5.4 - $8.47 $746,280 - $1.17 Million	138,200	138,200 $1.06 Million

Others Institutions Holding IMGN

# of Institutions

Shares Held

1.41M

Call Options Held

Put Options Held

View Full List

About ImmunoGen, Inc.

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

More about IMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Account